Market revenue in 2020 | USD 193.1 million |
Market revenue in 2028 | USD 412.0 million |
Growth rate | 9.9% (CAGR from 2020 to 2028) |
Largest segment | Reagents |
Fastest growing segment | Equipment |
Historical data covered | 2016 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents, Equipment |
Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Qiagen NV, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Merck KGaA, Origin Enterprises PLC, MaxCyte Inc, PromoCell GmbH, Promega, Polyplus-transfection, Horizon Discovery |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transfection reagents & equipment market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 54.69% in 2020. Horizon Databook has segmented the Asia Pacific transfection reagents & equipment market based on reagents, equipment covering the revenue growth of each sub-segment from 2016 to 2028.
This is attributed to improvements in healthcare infrastructure and the increase in research initiatives at academic & organizational levels in this region. Asia Pacific holds a large pool of patients with infectious diseases, which is driving demand for gene expression studies, transgenic modeling, and drug development, in turn driving the market.
Collaborative initiatives undertaken by several leading market players to expand their geographical reach are anticipated to increase market revenue significantly.
Considerably larger investments in healthcare research and economic enhancements are further expected to strengthen market potential by 2028. Presence of favorable government initiatives promoting entrepreneurship and innovation is expected to open up new capitalization avenues in the market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific transfection reagents & equipment market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific transfection reagents & equipment market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account